Dapagliflozin for heart function after Fontan procedure
Part of Genetic & congenital, Heart & circulation clinical trials.
This trial tests whether dapagliflozin, a diabetes drug that also helps the heart, can improve exercise ability and heart function in people who have had the Fontan procedure for a single ventricle heart defect.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have had the Fontan procedure for a single ventricle heart condition.
- You are at least 12 years old and weigh 30 kg (66 lbs) or more.
- You have not used any SGLT2 inhibitor (like dapagliflozin, empagliflozin) in the last 6 months.
- You do not have serious kidney disease, current infections, or diabetes that requires insulin.
- You are not pregnant or breastfeeding.
- You can do an exercise test on a bike or treadmill.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a diabetes medication called dapagliflozin can help improve how well the right side of your heart works after off-pump coronary artery bypass grafting surgery (a way to reroute blood around blocked heart arteries). The goal is to see if this drug reduces strain on your heart during recovery.
This study tests whether a medicine called an SGLT2 inhibitor (which lowers blood sugar and helps the kidneys) can improve outcomes for people with acute heart failure and kidney problems. Participation involves taking the study drug or a placebo for a short time.
This study tests whether dapagliflozin (a medicine already approved for other heart conditions) can help protect kidney and heart function in people with very advanced heart failure who are waiting for a heart transplant. If you qualify, you'll help researchers learn if this drug offers extra benefits beyond standard care.
This study tests a type of diabetes medicine (SGLT2 inhibitor) to see if it can help people who had surgery for tetralogy of Fallot feel better and have stronger heart and lung function. It may be a good fit if you are an adult with repaired tetralogy of Fallot and do not have certain other health problems.
This study tests whether a medication called dapagliflozin (a pill for heart failure) can help people with a Fontan circulation who feel short of breath. It aims to improve symptoms and quality of life.
This study tests whether a medicine called dapagliflozin can improve heart function in people hospitalized with acute heart failure. It may help the heart pump more efficiently and improve recovery.
Hear when a new Fontan trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.